CY1114960T1 - Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου - Google Patents

Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου

Info

Publication number
CY1114960T1
CY1114960T1 CY20141100195T CY141100195T CY1114960T1 CY 1114960 T1 CY1114960 T1 CY 1114960T1 CY 20141100195 T CY20141100195 T CY 20141100195T CY 141100195 T CY141100195 T CY 141100195T CY 1114960 T1 CY1114960 T1 CY 1114960T1
Authority
CY
Cyprus
Prior art keywords
tramadoli
sellekoxibe
compositions including
pain treatment
treatment
Prior art date
Application number
CY20141100195T
Other languages
English (en)
Inventor
Salido Enrique Portillo
CES Sebastià VIDELA
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114960(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of CY1114960T1 publication Critical patent/CY1114960T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε φαρμακευτικές συνθέσεις που περιλαμβάνουν τραμαδόλη και σελεκοξίμπη και χρήσεις αυτών ως φάρμακα ή αναλγητικά, ειδικότερα για την θεραπεία σοβαρού έως μετρίου πόνου με φλεγμονώδες συστατικό.
CY20141100195T 2009-10-16 2014-03-10 Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου CY1114960T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09384004A EP2311446A1 (en) 2009-10-16 2009-10-16 Compositions comprising Tramadol and Celecoxib in the treatment of pain
EP10765762.9A EP2488170B1 (en) 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain

Publications (1)

Publication Number Publication Date
CY1114960T1 true CY1114960T1 (el) 2016-12-14

Family

ID=41566149

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100195T CY1114960T1 (el) 2009-10-16 2014-03-10 Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου

Country Status (34)

Country Link
US (3) US8569271B2 (el)
EP (3) EP2311446A1 (el)
JP (2) JP5579858B2 (el)
KR (1) KR101688996B1 (el)
CN (2) CN107050006A (el)
AR (1) AR078653A1 (el)
AU (1) AU2010306114B2 (el)
BR (1) BR112012005044B8 (el)
CA (1) CA2771651C (el)
CO (1) CO6511249A2 (el)
CY (1) CY1114960T1 (el)
DK (1) DK2488170T3 (el)
EC (1) ECSP12011735A (el)
ES (1) ES2450615T3 (el)
HK (1) HK1173379A1 (el)
HR (1) HRP20140157T1 (el)
IL (1) IL218096A (el)
IN (1) IN2012DN01434A (el)
MA (1) MA33743B1 (el)
MX (1) MX2012003051A (el)
MY (1) MY156275A (el)
NZ (1) NZ598361A (el)
PL (1) PL2488170T3 (el)
PT (1) PT2488170E (el)
RS (1) RS53202B (el)
RU (2) RU2012120087A (el)
SG (1) SG178833A1 (el)
SI (1) SI2488170T1 (el)
SM (1) SMT201400035B (el)
TN (1) TN2012000059A1 (el)
TW (1) TWI466668B (el)
UA (1) UA108213C2 (el)
WO (1) WO2011045075A1 (el)
ZA (1) ZA201202151B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
US8746719B2 (en) 2010-08-03 2014-06-10 Polaris Industries Inc. Side-by-side vehicle
US20140088199A1 (en) * 2011-04-05 2014-03-27 Optosolve Llp Ophthalmic treatments
PL2965759T3 (pl) * 2012-02-06 2020-05-18 Innovative Med Concepts, LLC Terapia skojarzona związkiem przeciwwirusowym i inhibitorem cox-2 dla fibromialgii
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
US9572819B2 (en) * 2015-05-28 2017-02-21 Dr. Reddy's Laboratories, Ltd. Oral composition of celecoxib for treatment of pain
KR101710792B1 (ko) 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
BR112018074486A2 (pt) * 2016-05-27 2019-05-28 Dr Reddy´S Laboratories Ltd composição oral de celecoxib para tratamento da dor
KR102033716B1 (ko) * 2017-04-03 2019-10-17 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
WO2018186650A2 (ko) * 2017-04-03 2018-10-11 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
BR112021020893A2 (pt) * 2019-05-14 2022-04-19 Esteve Pharmaceuticals Sa Uso de cocristais de tramadol e celecoxib para o tratamento de dor, ao mesmo tempo que reduzindo a suscetibilidade a abuso do tramadol
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
WO2000051685A1 (en) 1999-03-01 2000-09-08 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
EP1478366B1 (en) * 2002-02-19 2008-12-03 Adcock Ingram Limited Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
NZ598353A (en) * 2009-10-16 2014-01-31 Esteve Labor Dr Co-crystals of tramadol and coxibs
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
CO6511249A2 (es) 2012-08-31
HK1173379A1 (en) 2013-05-16
UA108213C2 (uk) 2015-04-10
US20120172341A1 (en) 2012-07-05
DK2488170T3 (en) 2014-03-03
AR078653A1 (es) 2011-11-23
TWI466668B (zh) 2015-01-01
SI2488170T1 (sl) 2014-04-30
CA2771651A1 (en) 2011-04-11
ZA201202151B (en) 2012-11-28
MX2012003051A (es) 2012-05-29
HRP20140157T1 (hr) 2014-03-28
EP2737898A1 (en) 2014-06-04
EP2488170B1 (en) 2014-01-22
BR112012005044B8 (pt) 2021-05-25
IN2012DN01434A (el) 2015-06-05
AU2010306114B2 (en) 2015-07-23
CN107050006A (zh) 2017-08-18
RS53202B (en) 2014-06-30
EP2488170A1 (en) 2012-08-22
IL218096A (en) 2015-02-26
SG178833A1 (en) 2012-05-30
CN102573824A (zh) 2012-07-11
CA2771651C (en) 2016-08-23
US20150150889A1 (en) 2015-06-04
SMT201400035B (it) 2014-05-07
PT2488170E (pt) 2014-03-11
ECSP12011735A (es) 2012-05-30
RU2012120087A (ru) 2013-11-27
NZ598361A (en) 2014-01-31
MY156275A (en) 2016-01-29
EP2311446A1 (en) 2011-04-20
US20140024622A1 (en) 2014-01-23
WO2011045075A1 (en) 2011-04-21
IL218096A0 (en) 2012-04-30
TN2012000059A1 (en) 2013-09-19
US8569271B2 (en) 2013-10-29
AU2010306114A1 (en) 2012-03-15
MA33743B1 (fr) 2012-11-01
KR101688996B1 (ko) 2016-12-22
JP2013507408A (ja) 2013-03-04
PL2488170T3 (pl) 2014-05-30
JP2014221797A (ja) 2014-11-27
RU2707752C2 (ru) 2019-11-29
BR112012005044A2 (pt) 2016-05-03
RU2016125895A3 (el) 2018-12-05
ES2450615T3 (es) 2014-03-25
TW201114418A (en) 2011-05-01
JP5579858B2 (ja) 2014-08-27
RU2016125895A (ru) 2018-12-05
KR20120089287A (ko) 2012-08-09
BR112012005044B1 (pt) 2020-12-15

Similar Documents

Publication Publication Date Title
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1122480T1 (el) Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
CY1119660T1 (el) Antibakthpiakh απο toy στοματος συνθεση
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
EA201170832A1 (ru) Пуриновые соединения
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
BR112014021531A8 (pt) composto, composição farmacêutica e usos dos mesmos
MX2010003299A (es) Oligonucleotidos muy cortos (micromirs).
CR20120202A (es) Métodos y composiciones para tratar cáncer
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
CY1117785T1 (el) Αναστολεας φωσφοϊνοσιτιδιου 3-κινασης με ενα τμημα δεσμευσης ψευδαργυρου
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.